Anlotinib combined with temozolomide for the treatment of patients with diffuse midline glioma: a case report and literature review

BACKGROUND: Diffuse midline glioma with a histone H3-K27M mutation is a brand-new tumor entity according to the 2016 edition of World Health Organization (WHO) classification. As diffuse midline gliomas are aggressive and incurable brain tumors, characterized by high levels of intrinsic and acquired...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yiping, Xu, Qingsheng, Fang, Minwei, Hu, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641137/
https://www.ncbi.nlm.nih.gov/pubmed/36388022
http://dx.doi.org/10.21037/tcr-22-1073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641137/
https://www.ncbi.nlm.nih.gov/pubmed/36388022
http://dx.doi.org/10.21037/tcr-22-1073

Ejemplares similares